| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2004 | US20040072825 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof |
| 04/15/2004 | US20040072824 Administering antihistamine |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072821 N-substituted glycine derivatives |
| 04/15/2004 | US20040072820 Naphthyl compounds, intermediates, compositions, and methods of use |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072815 Antibiotic composition and method |
| 04/15/2004 | US20040072814 Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| 04/15/2004 | US20040072813 Estrogenic compounds as anti-mitotic agents |
| 04/15/2004 | US20040072812 Extraction from pregnant horse urine; hormone replacement therapy |
| 04/15/2004 | US20040072811 Use of antiprogestins for the induction of apoptosis in a cell |
| 04/15/2004 | US20040072810 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| 04/15/2004 | US20040072809 Antiinflammatory agents; analgesics; dilation; reducing pressure; therapy for vision defects |
| 04/15/2004 | US20040072808 Menopause; hormone replacement therapy; controlling dosage |
| 04/15/2004 | US20040072807 Methods of treating antifungal infections using lupeol |
| 04/15/2004 | US20040072806 Neuroprotective spirostenol pharmaceutical compositions |
| 04/15/2004 | US20040072804 Anticancer agents; skin disorders; bone disorders |
| 04/15/2004 | US20040072803 Novel compounds for modulating cell proliferation |
| 04/15/2004 | US20040072801 Supplying oxygen to red blood cells; complex of inositol and sterol; antiischemic agents; cardiovascular disorders |
| 04/15/2004 | US20040072798 Compositions comprising cyclodextrins and no-releasing drugs |
| 04/15/2004 | US20040072797 In liquid siolvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/15/2004 | US20040072796 Method and composition for preventing pain in sickle cell patients |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072792 Local anesthetic and agent for maintaining anesthetic action; acidic mucopolysaccharide or a cellulose derivative; does not contain a catecholamine; for oral surgery or dental treatment; sodium chondroitin sulfate; hydroxypropylmethylcellulose |
| 04/15/2004 | US20040072791 Method for producing pectin hydrolysis products |
| 04/15/2004 | US20040072790 Homoharringtonine combined with Matrine, Apigenin, Yejuhua lactone, Lipopolysaccharide of Kelp, Puerarin, or Indirubin; culture method for production of HHT from plant extract for increased production of HHT |
| 04/15/2004 | US20040072789 Veterinary composition for the topical treatment of traumatized or inflamed skin |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072785 Ischemia; polynucleotide for transfection; polynucleotide is inserted into an artery or a vein; prior to injection the volume of the muscle tissue is increased such that the genetic material is delivered to the parenchymal cell |
| 04/15/2004 | US20040072784 Micelles formed from amphiphilic polymers associate or dissociate reversibly upon ph changes; oral or parenteral delivery of hydrophobic or cationic pharmaceutical; copolymer of polyethylene oxide and polyacrylic acid-butyl acrylate |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072776 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040072766 Bioassay for screening an inhibitor or activator of phosphatidylinositol 3-kinase, finding immunostimulants, or immunosuppressants |
| 04/15/2004 | US20040072765 A therapeutic drug mixtures comprising formononetin and isoflavones selected from biochanin, genistein and daidzein; adjusting blood lipoprotein levels for heart diseases, increase bone density for osteoporosis, bone fracture |
| 04/15/2004 | US20040072764 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least an isoflavonoid |
| 04/15/2004 | US20040072763 Pharmaceutical composition |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072761 Heterocyclicsulfonamide hepatitis C virus inhibitors |
| 04/15/2004 | US20040072760 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072750 Administering an antibodies of antigen protein as thrombolytic agents, anticoagulants |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/15/2004 | US20040072733 Anti-viral composition |
| 04/15/2004 | US20040072732 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072725 Orinithine and/or one or more branched amino acids(leucine, isoleucine and valine) in a concentration effective for treating or preventing inflammatory disease such as arthritis |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072205 Using minocycline to reduce cytochrome c release and treat amyotrophic lateral sclerosis and brain disorders |
| 04/15/2004 | US20040072201 Methods of identifying compounds that inhibit nonstop degradation of mRNA |
| 04/15/2004 | US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072144 Administering antiviral agents; measuring immunoglobulin/ antibody levels |
| 04/15/2004 | US20040072138 Attenuation of ischemia/reperfusion injury |
| 04/15/2004 | US20040071855 Use of N-acetylglucosamine as an additive to foods and beverages wherein each single serving size of food and beverage comprises from about 0.1 grams to 20 grams of N-acetylglucosamine |
| 04/15/2004 | US20040071824 Nutritional composition with health promoting action contaning oligosaccharides |
| 04/15/2004 | US20040071800 Method of reducing low density lipoprotein cholesterol concentration |
| 04/15/2004 | US20040071798 Administering to a mammal in acosmetic/dermatological formulation which comprises intimate admixture of at least one carotenoid and at least one extract of at least one plant of genus Rosmarinus for therapy of skin aging |
| 04/15/2004 | US20040071794 Administering methysticin, dihydromethysticin, desmethoxyyangonin, yangonin, dihydrokavain, and/or kavain as drug intensifier |
| 04/15/2004 | US20040071793 Oral rehydration methods and compositions |
| 04/15/2004 | US20040071792 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity |
| 04/15/2004 | US20040071779 Gelled laxative compositions |
| 04/15/2004 | US20040071778 Gel administered as drops or ointment with free-flowing vehicle and benzyllauryldimethylammonium chloride preservative |
| 04/15/2004 | US20040071777 In hydrophilic cellulose ether, polyvinyl pyrrolidone, or polyethylene glycol; amorphous |
| 04/15/2004 | US20040071775 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 04/15/2004 | US20040071774 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 04/15/2004 | US20040071771 Fenofibrate-containing composition |
| 04/15/2004 | US20040071770 Free radical scavenging liposome containing mixture of beta-carotene, vitamin E, vitamin C, glutathione, niacin, and/or trace metal; quenching |
| 04/15/2004 | US20040071768 Compositions and methods for treating cancer |
| 04/15/2004 | US20040071767 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | US20040071764 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 04/15/2004 | US20040071761 Non-invasive ocular drug delivery |
| 04/15/2004 | US20040071751 Blood neutral fat concentration controlling agent and method of controlling neutral fat concentration in blood |
| 04/15/2004 | US20040071749 DNA or protein biosynthesis in dermal cells; topically applied |
| 04/15/2004 | US20040071748 Stable hydroalcoholic compositions |
| 04/15/2004 | US20040071745 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging |
| 04/15/2004 | US20040071744 Gene expression inhibition of collagenases; skin wrinkle resistance |
| 04/15/2004 | US20040071740 Mixture of hyaluronic acids of different molecular weights in diluent |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071701 Nerve growth factor antagonist for treating pain caused by physiological disorder, no side effects |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071682 Super absorption coenzyme Q10 |
| 04/15/2004 | US20040071681 Administering 5-hydroxytryptophan in substance similar to desired consumable |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071645 Glucocorticoid formulation; penetration, bioavailability |
| 04/15/2004 | US20040070005 Compact high voltage ESD protection diode |
| 04/15/2004 | US20040069523 Use of Vitamin D-Derivatives in the Treatment of Osteoporosis and related bone disorders, as well as novel vitamin D3-Deviratives |
| 04/15/2004 | DE4325927B4 Taxol enthaltender Medikamentierungskit Taxol-containing Medikamentierungskit |
| 04/15/2004 | DE4201903B4 Pharmazeutische Verwendung von Boswelliasäuren Pharmaceutical use of boswellic acids |
| 04/15/2004 | DE20319986U1 Topical composition containing dimethyl sulfoxide (DMSO) and dexapanthenol, useful for treating e.g. injuries and rheumatic disease, can contain high concentration of DMSO without causing skin irritation |